Novel toxin receptor discovered for ulcer-causing stomac...( Helicobacter pylori is one tough bug...),Health
Helicobacter pylori is one tough bug. It can survive in the human stomach, a zone with a pH somewhere between that of lemon juice and battery acid. Now researchers have discovered how an H. pylori toxin gets into cells, a feat that helps the bacterium live in one of the most inhospitable environments in the body.
Their findings appear this week in PLoS Pathogens, a journal of the Public Library of Science.
About half of the worlds population is infected with H. pylori, although most of them dont know it (most infected people have no obvious symptoms). For a percentage of the infected, however, the bacterium packs a nasty punch. H. pylori is responsible for most human cases of gastric and duodenal ulcers, and long-term infection is a significant risk factor for stomach cancer, the second leading cause of cancer death worldwide.
Researchers have tried for years to understand how the bacterium survives in the human stomach, said Steven Blanke, a University of Illinois professor in the department of microbiology and Institute for Genomic Biology and principal investigator on the study.
Paradoxically, although H. pylori is a common resident of the human stomach, the bug is not well adapted by itself to acid, he said. But this pathogen has several clever mechanisms for carving out a niche for itself in the stomach lining.
A protein produced by H. pylori, called vacuolating toxin A (VacA), is an important weapon in its arsenal.
This toxin gets into stomach epithelial cells and immune cells and changes their properties in such a way as to allow H. pylori to first gain a foothold in the stomach, and then survive over the long-term, which may be the entire lifetime of an individual, Blanke said.
H. pylori releases the VacA toxin in order to modify its environment, he said.
How the toxin crossed the membrane to get into these cells was a mystery, however.
Cell membranes are composed prima
'/>"/>
| Contact: Diana Yates diya@illinois.edu 217-333-5802 University of Illinois at Urbana-Champaign Source:Eurekalert |
Related medicine news :
1. Novel enzyme inhibitor paves way for new cancer drug
2. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
3. Novel mechanisms controlling insulin release and fat deposition discovered
4. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
5. Discovery of a novel mechanism for the development of colon cancer
6. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
7. Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis
8. Scientists identify novel way to prevent cardiac fibrosis
9. Registry unveils real-world data on novel excel stent
10. Researchers sharpen search for new marine medicines with novel techniques
11. Increased hepcidin expression: A novel oncogenic signalling mechanism
 Novel toxin receptor discovered for ulcer-causing stomach pathogen |
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |